恒瑞医药可以一点一点建仓。

TradingView2021-08-16

恒瑞医药可以一点一点建仓。

JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. SSE:600276

hujianghua

1、恒瑞医药月线看布林带下轨有支撑。 2、斐波那契回撤到0.618黄金分割线，54.67的位置，同布林带产生支撑共振。 3、这个位置我们可以一点一点建仓，不超过总仓位的20%。 4、耐心等待打破红色下跌趋势线后，右侧大仓位买入是最稳妥的。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

北_4560
2021-08-19
北_4560
还有天理没，天天爹

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2160271696?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015","is_english":false,"pubTime":"2021-08-16 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2160271696","market":"us","top_or_hot":-1,"title":"恒瑞医药可以一点一点建仓。","media":"TradingView","content":"<html><body><div>\n<img height=\"32\" src=\"https://s3.tradingview.com/userpics/1988963-NFBn_mid.png\" width=\"32\"/>\n</div>\n<div>\n<h1><a href=\"https://laohu8.com/S/600276\">恒瑞医药</a>可以一点一点建仓。</h1>\n</div>\n<div>\nJIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. <span>SSE:600276</span>\n</div>\n<div>\nhujianghua\n</div>\n<img src=\"https://s3.tradingview.com/f/FEkQShry_mid.png\"/>\n<p>1、恒瑞医药月线看布林带下轨有支撑。 \n2、斐波那契回撤到0.618黄金分割线，54.67的位置，同布林带产生支撑共振。 \n3、这个位置我们可以一点一点建仓，不超过总仓位的20%。 \n4、耐心等待打破红色下跌<a href=\"https://laohu8.com/S/42T.SI\">趋势线</a>后，右侧大仓位买入是最稳妥的。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>恒瑞医药可以一点一点建仓。</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n恒瑞医药可以一点一点建仓。\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-16 22:54 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cn.tradingview.com/chart/600276/FEkQShry/><strong>TradingView</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>恒瑞医药可以一点一点建仓。\n\n\nJIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. SSE:600276\n\n\nhujianghua\n\n\n1、恒瑞医药月线看布林带下轨有支撑。 \n2、斐波那契回撤到0.618黄金分割线，54.67的位置，同布林带产生支撑共振。 \n3、这个位置我们可以一点一点建仓，不超过总仓位的20%。 \n4、耐心等待打破红色下跌趋势线后，右侧大仓位买入是...</p>\n\n<a href=\"https://cn.tradingview.com/chart/600276/FEkQShry/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600276","symbol_name":"恒瑞医药","start_time":0,"source_url":"https://cn.tradingview.com/chart/600276/FEkQShry/","article_id":"2160271696","we_media_id":"1083892989","thumbnails":["https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2160271696","pubTimestamp":1629125676,"sourceInfo":null,"weMediaInfo":{"media_name":"TradingView","introduction":"Live quotes, stock charts and expert trading ideas. TradingView is a social network for traders and investors on Stock, Futures and Forex markets!","home_visible":1,"id":"1083892989","head_image":"https://static.tigerbbs.com/d298bab1e4184c87f17c1e0be9b9d329"},"summary":"恒瑞医药可以一点一点建仓。\n\n\nJIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. SSE:600276\n\n\nhujianghua\n\n\n1、恒瑞医药月线看布林带下轨有支撑。 \n2、斐波那契回撤到0.618黄金分割线，54.67的位置，同布林带产生支撑共振。 \n3、这个位置我们可以一点一点建仓，不超过总仓位的20%。 \n4、耐心等待打破红色下跌趋势线后，右侧大仓位买入是最稳妥的。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600276":"恒瑞医药"},"translate_title":"Jiangsu Hengrui Medicine Co.,Ltd. can build positions bit by bit.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600276":1},"content_text":"恒瑞医药可以一点一点建仓。\n\n\nJIANGSU HENGRUI PHARMACEUTICALS CO.,LTD. SSE:600276\n\n\nhujianghua\n\n\n1、恒瑞医药月线看布林带下轨有支撑。 \n2、斐波那契回撤到0.618黄金分割线，54.67的位置，同布林带产生支撑共振。 \n3、这个位置我们可以一点一点建仓，不超过总仓位的20%。 \n4、耐心等待打破红色下跌趋势线后，右侧大仓位买入是最稳妥的。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":831745039,"gmtCreate":1629353770021,"gmtModify":1629353770021,"author":{"id":"3546384736338140","authorId":"3546384736338140","name":"北_4560","avatar":"https://static.tigerbbs.com/711d3d2faa9de841ae9246d53fa589ec","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3546384736338140","authorIdStr":"3546384736338140"},"htmlText":"还有天理没，天天爹","listText":"还有天理没，天天爹","text":"还有天理没，天天爹","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/831745039","repostId":2160271696,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2160271696"}